Clinical trials

  • CAPECITABINE for Locally advanced rectal cancer | Rectal cancer stage III | Rectal cancer stage II
  • PRASTERONE for Genitourinary syndrome of menopause | Breast cancer
  • DAROVASERTIB for Metastatic uveal melanoma (HLA-A2 negative)
  • RITUXIMAB for Diffuse large B-cell lymphoma
  • ETENTAMIG for Relapsed or refractory multiple myeloma
  • UPADACITINIB for Non-segmental vitiligo
  • 5-(4-((2S,5S)-5-(4-CHLOROBENZYL)-2-METHYLMORPHOLINO)PIPERIDIN-1-YL)-1H- 1,2,4-TRIAZOL-3-AMINE for Pulmonary sarcoidosis
  • INFLUENZA VIRUS B/AUSTRIA/1359417/2021 - LIKE STRAIN; INFLUENZA VIRUS A/VICTORIA/4897/2022 (H1N1)PDM09 - LIKE STRAIN; INFLUENZA VIRUS A/THAILAND/8/2022 (H3N2)-LIKE STRAIN for Influenza
  • BEVACIZUMAB for Metastatic colorectal cancer
  • Gemcitabine hydrochloride for Non‑muscle-invasive bladder cancer (NMIBC)
  • Amivantamab for Non-small cell lung cancer (EGFR exon 20 insertion-mutated, locally advanced or metastatic)
  • TOFACITINIB for Ulcerative colitis